Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Haisco's HSK39004 Gains NMPA Approval for COPD Clinical Trials
CompanyDrug

Haisco’s HSK39004 Gains NMPA Approval for COPD Clinical Trials

February 6, 2025
Sino Medical Sciences' NC Rockstar Catheter Gains MDA Approval in Malaysia
CompanyMedical Device

Sino Medical Sciences’ NC Rockstar Catheter Gains MDA Approval in Malaysia

February 6, 2025
Henan Lingrui Yingu Pharma Anticholinergic Drug
CompanyDeals

Henan Lingrui to Acquire Yingu Pharma for RMB 704 Million

February 6, 2025
Junshi Biosciences Receives NMPA Approval for JS213 Clinical Trials
CompanyDrug

Junshi Biosciences Receives NMPA Approval for JS213 Clinical Trials

February 6, 2025
Beijing Biostar's Utidelone Gains FDA Approval for Global Phase II/III Study
CompanyDrug

Beijing Biostar’s Utidelone Gains FDA Approval for Global Phase II/III Study

April 2, 2025
ClouDr Group Integrates DeepSeeker R1 into CloudrBrain to Boost Chronic Disease Management
CompanyDeals

ClouDr Group Integrates DeepSeeker R1 into CloudrBrain to Boost Chronic Disease Management

February 6, 2025
Henlius' Serplulimab Receives EU Approval for Extensive-Stage Small Cell Lung Cancer
Company

Henlius’ Serplulimab Receives EU Approval for Extensive-Stage Small Cell Lung Cancer

February 6, 2025
Harbour BioMed Receives NMPA Clearance for COPD Treatment HBM9378/SKB378
CompanyDrug

Harbour BioMed Receives NMPA Clearance for COPD Treatment HBM9378/SKB378

February 6, 2025
Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms
CompanyDeals

Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms

February 5, 2025
Becton Dickinson Considers Spinning Off Life Sciences Division
CompanyDeals

Becton Dickinson Considers Spinning Off Life Sciences Division

February 5, 2025
Vantive Launches as Standalone Vital Organ Therapy Company Post Carlyle Acquisition
CompanyDeals

Vantive Launches as Standalone Vital Organ Therapy Company Post Carlyle Acquisition

February 5, 2025
Nona Biosciences Partners with Invetx for Animal Health Therapies
CompanyDeals

Nona Biosciences Partners with Invetx for Animal Health Therapies

February 5, 2025
1 2 … 259 260 261 262 263 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up